Nuformix plc (LON:NFX – Get Free Report)’s stock price was down 12% during mid-day trading on Wednesday . The stock traded as low as GBX 0.41 and last traded at GBX 0.43. Approximately 243,141,344 shares were traded during mid-day trading, an increase of 321% from the average daily volume of 57,801,742 shares. The stock had previously closed at GBX 0.49.
Nuformix Price Performance
The firm has a 50-day moving average price of GBX 0.21 and a 200 day moving average price of GBX 0.14. The company has a market cap of £6.94 million, a price-to-earnings ratio of -1.02 and a beta of 1.22.
Nuformix Company Profile
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.
See Also
- Five stocks we like better than Nuformix
- The Basics of Support and Resistance
- 3 Potential Scenarios to Watch for in D-Wave’s Earnings Report
- What is a Death Cross in Stocks?
- Eli Lilly Posts Stellar Q3: Long-Term Upside Is Well in Play
- What is Short Interest? How to Use It
- Uber Is Crushing Lyft—And It’s Not Even Close
Receive News & Ratings for Nuformix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuformix and related companies with MarketBeat.com's FREE daily email newsletter.
